期刊
TRENDS IN BIOTECHNOLOGY
卷 23, 期 2, 页码 57-59出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2004.12.011
关键词
-
In an exciting recent paper Richard Vile and coworkers describe a novel approach to tumor immunotherapy based on the killing of a population of normal cells within an inflammatory environment. This approach builds on recent studies showing that the molecular chaperone Hsp70 can act at multiple stages during tumor antigen presentation to enhance the generation of CD8(+) T lymphocyte-mediated immunity and lead to regression of primary and metastatic tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据